TRI completes growth capital fundraising round led by Octopus Investments
TRI, a leading global provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has completed a growth capital fundraise to accelerate development of its core technology platform, OPRA and expand its international presence. Funding was raised through Octopus Investments, part of the Octopus Group headquartered in London. Founded in